Physician profile
Jacqueline E Conger
NPI 1396162400
$1,442.56
in general payments reported to CMS, 2019-2025
21 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2021: $97.35 · 2022: $225 · 2023: $190 · 2024: $451 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $964.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $373.01 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Organon LLC | $147.95 | 2022-2025 | Nexplanon, Jada System |
| Medtronic, INC. | $135.09 | 2024 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $130.60 | 2022-2024 | |
| Exeltis, USA INC. | $111.53 | 2022-2025 | Slynd |
| Astellas Pharma US INC | $88.93 | 2023-2025 | Veozah |
| Channel Medsystems, INC. | $70.69 | 2024 | |
| Conmed Corporation | $62.22 | 2025 | Airseal |
| Biogen, INC. | $52.94 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $49.28 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $35.22 | 2023-2024 | |
| Organogenesis INC. | $33.28 | 2025 | Cygnus Matrix |
| Therapeuticsmd, INC. | $25.26 | 2021-2022 | |
| Daiichi Sankyo INC. | $19.86 | 2024 | Injectafer |
| Sumitomo Pharma America, INC. | $19.73 | 2025 | Myfembree |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.21 | 2023 | Gardasil 9 |
| Coloplast Corp | $15.18 | 2024 | |
| Millicent US INC | $14.92 | 2025 | Intrarosa, Femlyv |
| Pfizer INC. | $14.05 | 2025 | |
| Minerva Surgical, INC | $13.90 | 2022 | |
| Hologic Sales and Service, LLC | $13.71 | 2024 | Acessa Provu System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Conger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.